
HUWE 1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation
Author(s) -
Myant Kevin B,
Cammareri Patrizia,
Hodder Michael C,
Wills Jimi,
Von Kriegsheim Alex,
Győrffy Balázs,
Rashid Mamun,
Polo Simona,
Maspero Elena,
Vaughan Lynsey,
Gurung Basanta,
Barry Evan,
Malliri Angeliki,
Camargo Fernando,
Adams David J,
Iavarone Antonio,
Lasorella Anna,
Sansom Owen J
Publication year - 2017
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.201606684
Subject(s) - cancer , estate , library science , cancer genetics , medicine , cancer research , political science , law , computer science
Cancer genome sequencing projects have identified hundreds of genetic alterations, often at low frequencies, raising questions as to their functional relevance. One exemplar gene is HUWE 1 , which has been found to be mutated in numerous studies. However, due to the large size of this gene and a lack of functional analysis of identified mutations, their significance to carcinogenesis is unclear. To determine the importance of HUWE 1 , we chose to examine its function in colorectal cancer, where it is mutated in up to 15 per cent of tumours. Modelling of identified mutations showed that they inactivate the E3 ubiquitin ligase activity of HUWE 1. Genetic deletion of Huwe1 rapidly accelerated tumourigenic in mice carrying loss of the intestinal tumour suppressor gene Apc , with a dramatic increase in tumour initiation. Mechanistically, this phenotype was driven by increased MYC and rapid DNA damage accumulation leading to loss of the second copy of Apc . The increased levels of DNA damage sensitised Huwe1 ‐deficient tumours to DNA ‐damaging agents and to deletion of the anti‐apoptotic protein MCL 1. Taken together, these data identify HUWE 1 as a bona fide tumour suppressor gene in the intestinal epithelium and suggest a potential vulnerability of HUWE 1 ‐mutated tumours to DNA ‐damaging agents and inhibitors of anti‐apoptotic proteins.